Fig. 3From: Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patientsComparison of each sign scores (a) and symptom scores (b) among disease groups during the follow-up period. It shows the changes in both scores during the treatment period for each diseaseBack to article page